Polar Capital’s Halozyme HALO Stock Holding History

Polar Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-30,649	Closed	-$531K	–	272
2015 Q4	$531K	Buy	+30,649	New	+$489K	0.01%	248

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Polar Capital's HALO Position: Q1 2016 in Review

Polar Capital sold out of Halozyme (HALO) in Q1 2016, closing a stake of 30,649 shares — an estimated $531K sold.

Polar Capital first reported a position in HALO in Q4 2015 and held it in 1 quarter. The position peaked at $531K in Q4 2015. 161 funds tracked by Wall St. Rank hold HALO as of Q1 2016.

Polar Capital reported no remaining Halozyme position as of Q1 2016 after selling out during the quarter.
Polar Capital sold 30,649 Halozyme shares in Q1 2016, an estimated $531K.
Polar Capital first reported a position in Halozyme in Q4 2015 and held it in 1 quarter.
Polar Capital's Halozyme position peaked at $531K in Q4 2015.
161 funds tracked by Wall St. Rank held Halozyme as of Q1 2016.

Based on Polar Capital's 13F filing for Q1 2016, filed 16 May 2016.